Imperial College London Featured PhD Programmes
Engineering and Physical Sciences Research Council Featured PhD Programmes
Life Science Zurich Graduate School Featured PhD Programmes
"antimicrobial"×
10 miles

antimicrobial PhD Projects, Programs & Scholarships

We have 101 antimicrobial PhD Projects, Programs & Scholarships

  • "antimicrobial" ×
  • clear all
Order by 
Showing 1 to 15 of 101
  Medical Research Foundation National PhD Training Programme in Antimicrobial Resistance Research: Hobby Farming: Exploring Human-Animal Interactions, Disease Management and Antimicrobial Resistance on Smallholder Farms
  Dr K Reyher, Prof H Buller
Application Deadline: 22 June 2020

Funding Type

PhD Type

This 3.5 year, fully funded PhD, seeks to examine the relationships of hobby farmers with their animals and with animal disease, with a distinct focus on antimicrobial use and resistance.
  Protease-resistant antimicrobial peptides to target bacterial and fungal pathogens
  Dr J Bella, Dr L Tabernero
Applications accepted all year round

Funding Type

PhD Type

Antimicrobial resistance is quickly becoming a serious global health problem. The emergence of multidrug-resistant microbial strains combined with the drying up of the antibiotic pipeline in the pharmaceutical industry has significantly worsened the situation in recent years.
  Surface functionalized nanodiamonds for antimicrobial applications
  Prof H Ye, Prof MR Oggioni
Application Deadline: 7 June 2020

Funding Type

PhD Type

Objective. The project is to develop novel surface functionalized nanodiamonds for antimicrobial applications against antibiotic resistant bacteria.
  Targeting the Unfolded Protein Response to Develop Novel Antimicrobial Therapies (Ref: SF20/APP/DOVER)
  Dr LG Dover
Applications accepted all year round

Funding Type

PhD Type

Microbial pathogen resistance to antibiotics is an ever growing global concern. Antibiotics generally target microbial pathways important for survival and replication.
  Targeting pathogen subversion of cellular ageing to combat antimicrobial-resistant typhoid fever
  Dr D Humphreys, Dr T Darton
Applications accepted all year round

Funding Type

PhD Type

Antimicrobial-resistant typhoid fever is fuelled by chronic Salmonella carriage. The world faces epidemics of untreatable typhoid fever caused by antimicrobial-resistant strains of Salmonella Typhi (~27 million cases/year).
  Genome mining of novel antimicrobial and antiviral natural products from new bacterial strains
  Dr H Deng, Dr R Ebel
Applications accepted all year round

Funding Type

PhD Type

Antimicrobial resistance (AMR) is rising to dangerously high levels in all parts of the world. In Europe alone, drug-resistant bacteria are estimated to cause 25,000 deaths annually and cost more than US$1.5 billion every year in healthcare expenses and productivity losses.
  GW4 FRESH CDT PhD Studentship - Stereoisomerism of antimicrobial agents and risks to freshwater ecosystems
  Prof B Kasprzyk-Hordern
Application Deadline: 11 June 2020

Funding Type

PhD Type

GW4 FRESH is a consortium of the UK’s top research intensive universities. Bath, Bristol, Cardiff and Exeter and research organisations, British Geological Society and the Centre for Ecology and Hydrology.
  Understanding and combatting antimicrobial resistance plasmids
  Dr M Buckner, Dr J Blair
Applications accepted all year round

Funding Type

PhD Type

Antimicrobial resistance (AMR) is a major crisis for human medicine. Globally, untreatable bacterial infections are rapidly increasing, leaving us with limited treatment options.
  Optimising the nursing contribution to improving antimicrobial stewardship in hospitals: development of a multi-component intervention
  Research Group: Safeguarding Health through Infection Prevention
  Dr V Ness, Dr D McDonald
Applications accepted all year round

Funding Type

PhD Type

Ref. SHLS20033 Ness. ‘Antimicrobial resistance’ (AMR) means that many antibiotics may not work in future, putting hospital patients at increased risk of serious infections.
  Uncovering the role of lipid renovation in bacteria-host interactions
  Dr Y Chen, Prof D J Scanlan
Application Deadline: 7 June 2020

Funding Type

PhD Type

Antimicrobial resistance is one of the most serious threats to humans in the 21stcentury. Hence, understanding antimicrobial resistance mechanisms is pivotal for combating superbugs that are constantly emerging.
  Understanding multi-component remedies from historical medical texts
  Dr E Connelly, Dr F Harrison
Application Deadline: 7 June 2020

Funding Type

PhD Type

There is an urgent need for novel routes to drug discovery due to the significant increase in antibiotic-resistant microbes (AMR) and the lack of new drugs currently in development to treat antibiotic-resistant infections.
  Microalgae as an alternative for antimicrobial resistance pressure reduction
  Dr A Escudero
Application Deadline: 2 June 2020

Funding Type

PhD Type

This project is one of 16 four year PhD Studentships funded by Medical Research Scotland (https://www.medicalresearchscotland.org.uk) to be delivered jointly by the named University and External Partner Organisation (EPO).
  Investigating the role of the biofilm in waste water treatment plants as a reservoir for antimicrobial resistance
  Dr J Spencer, Dr J Roberts
Applications accepted all year round

Funding Type

PhD Type

Ref. SHLS20023 Spencer. Background. It has been reported that the rise/spread of antimicrobial resistance (AMR) will result in the premature deaths of 10 million people every year by 2050.
  Temperate bacteriophages and Antimicrobial Resistance (AMR) (Ref: SF20/APP/SMITH2)
  Dr D Smith
Applications accepted all year round

Funding Type

PhD Type

Bacterial genomes are studded with prophage regions, some that can be stimulated to produce active phages that horizontally transfer their genomes between related bacterial species.
  Antimicrobial prescribing in hospice and palliative care
  Dr C Parsons, Dr D Gilpin
Applications accepted all year round

Funding Type

PhD Type

Terminally ill patients are at high risk of infections and antimicrobial exposure near the end of life. However, the evidence-base to guide prescribers in the use of antibiotics for the treatment of infections in patients receiving hospice and palliative care is currently lacking.
Show 10 15 30 per page


FindAPhD. Copyright 2005-2020
All rights reserved.